Bio Path reported $0 in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Baxter International USD 11.01B 2.34B Jun/2026
Bio Path USD 1000K 0 Mar/2026
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Karyopharm Therapeutics USD 126M 9M Mar/2026